Clinical research in Sweden Current state and prospective Olle Stendahl, MD, PhD Dept. Molecular and Clinical Medicine Faculty of Health Sciences Linköping.

Slides:



Advertisements
Similar presentations
António de Sousa Pereira, MD, PhD. ICBAS UP Created in August 1975 Created in August 1975 Multidisciplinary School Multidisciplinary School Teaching staff.
Advertisements

Department of Medicine Task Force on Research. Committee Charge  Develop a unifying vision to become leaders in translational research Achieve top 10.
Senate Education Committee Briefing Russell Ingram, Executive Director March 23, 2011.
Welcome to the NIHR Peter Knight, Deputy Director Research Contracting, Information Intelligence and Stakeholder Engagement NIHR Trainees Meeting Leeds.
Building a Research CV Yeoh Khay Guan Deputy Chief Executive, NUHS Dean, NUS Yong Loo Lin School of Medicine 30 September 2014.
Joaquín Arenas Barbero Subdirector General de Evaluación y Fomento de la Investigación.
Policy recommendations for wider implementation of telemedicine Peeter Ross, MD, PhD e-Health expert, Estonian eHealth Foundation, Estonia.
Strategy 2012 Karolinska Institutet June 2010Strategy 2012.
Institute for Health and Society Institute for Health and Society Improving Health and Advancing Health Equity Through Community and Academic Partnerships.
Oakland University William Beaumont School of Medicine An Opportunity of a Lifetime.
Faculty of Medicine EDUCATION, RESEARCH AND INNOVATION SINCE 1666.
Getting Better Value for Money from Sweden’s Healthcare System By David Rae Presented by Allison Pokky.
Hepatitis and Liver Cancer A National Strategy for Prevention and Control of Hepatitis B and C.
Medicine, Nursing and Health Sciences School of Public Health & Preventive Medicine (SPHPM) Biomedical Science (BMS) Units,
CRICOS: 00116K Biomedical Engineer: Design products and procedures that solve medical problems. These include artificial organs, prostheses, instrumentation,
1 The UK Opportunity: what is experimental medicine? UNLOCK YOUR GLOBAL BUSINESS POTENTIAL Pre- clinical develop- ment Phase I Phase II Phase III Product.
Michelle Boudreau, Vice President, Private Markets, March 11, 2015 Presentation to CADA.
The Sanford World Clinics October, Brief History 116-year history with foundations in Sioux Falls, South Dakota and Fargo, North Dakota Sanford.
Cedars-Sinai Medical Center Capacity Building in Central and Eastern Europe: Research and Innovation Management Education and Training Innovation 2005.
Clinical aspects of smoking cessation Jean-Pierre Zellweger, MD Swiss Lung Association and Int. Union against TB and Lung Disease (The Union)
Building a Roadmap for Research IT John Brussolo Research IT Program Director September 6, 2012 © 2012 The Regents of the University of Michigan.
1 Karolinska University Hospital. –Presentation Heikki Teriö, FoU-manager Education:Applied Physics and Electronics Linkoping University of Technology.
Johns Hopkins Technology Transfer 1 Translational Biomedical Research: Moving Discovery from Academic Centers to the Community Translational Biomedical.
9/9/ “Health policy forum” Access to Health Care Promoting Primary Care Abdullah Alkhenizan, CCFP, ABHPM, MSc. DCEpid. Professor, AlFaisal University.
Challenges and opportunities in New Zealand’s pharmaceutical scene Kevin Sheehy – Chief Executive, Medicines New Zealand Dalton Kelly – Chief Executive,
Faculty of Medicine EDUCATION, RESEARCH AND INNOVATION SINCE 1666.
Global Leadership in Medical Innovation: “Ours to Lose”
Dr. José M. Millán, PhD Deputy Director of CIBERER Universitary Hospital La Fe, Valencia, Spain Barriers and Challenges in Rare Diseases Research Centre.
University of Virginia Developing a Research Program in Thoracic Surgery Grant Writing Workshop American Association of Thoracic Surgery David R. Jones.
Conducting Research in the UK National Health Service Dr Stephen Brett Reader In Critical Care.
Barriers to innovation – and solutions The Collaboration Conundrum Colette Goldrick, Director ABPI Northern Ireland.
Svetlana Spassova, MD Ministry of Health, Bulgaria Chisinau
MEDICAL INNOVATION March What Are The Public Health Benefits of Medical Innovation? Breakthrough medicines New devices Innovative medical procedures.
1 PRIORITY MEDICINES FOR EUROPE AND THE WORLD: a public health approach to innovation Hans V. Hogerzeil Director, Medicines Policy and Standards WHO, Geneva.
RETHINKING NEEDS-DRIVEN INNOVATION FROM THE SOUTH Access to Essential Medicines Initiative Seminar Public Health Program – Open Society Foundation (OSF)
The Innovative Medicines Initiative A winning case for Joint Technology Initiative Status.
Climate Change Uncertainties: Opportunities for Business Innovation? The Business Perspective: UPMC Allison Robinson, PhD, MS Director, Environmental Initiatives.
1 College of Pharmacy. The mission of the University of Michigan, College of Pharmacy is to prepare students to become pharmacists and pharmaceutical.
The NHS as a Challenged Institution- still a great benefit to mankind Dame Donna Kinnair.
How Does the Quality of Care Compare in Five Countries? Peter S. Hussey Johns Hopkins University and the Commonwealth Fund International Working Group.
PUTTING THE PATIENT AT THE CENTER OF HEALTHCARE RESEARCH Towards a more inclusive model.
Companies Government Private non-profit organisations Public research foundations From abroad Universities Governmental agencies Financiers of R&D Performers.
ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH Indiana CTSI 2014 Purdue Retreat Engagement with IU Health Arnett Marietta L. Harrison,
National Center for Research Resources G. Iris Obrams, M.D., M.P.H., Ph.D. NCRR Update 5 August 2006.
Team Building: Critical Role of Interdisciplinary Research Teams in Translational Research C. Kent Osborne, M.D. Director, Lester and Sue Smith Breast.
Scientific Opportunities and Public Needs Resource Allocation and Priority Setting at the NIH.
The Regional cancercenter of south Sweden - a project for the whole south swedish health region! Established 2010.
The U. S. Health Care System Challenges, Opportunities and Solutions Fifth National HIPAA Summit Clinical Data Standards and the Creation of an Interconnected,
KEYS TO SUCCESS NCURA Region IV Spring Meeting April 27 – 30, 2014 © 2014 National Council of University Research Administrators Managing Faculty Appointments.
Uses of the NIH Collaboratory Distributed Research Network Jeffrey Brown, PhD for the DRN Team Harvard Pilgrim Health Care Institute and Harvard Medical.
Communicable Diseases Alan J. Parkinson, Deputy Director Arctic Investigations Program, Centers for Disease Control & Prevention, USA.
Building the NIHR NIHR: 10 years of delivering health and care research for the nation QEII Centre, London Wednesday 18 May 2016 Professor Dame Sally C.
Professor Orla Hardiman HRB Clinician Scientist Innovation Its role in Delivering Better Health Outcomes.
History of Peptic Ulcer Treatment
The Research Landscape: Contextualizing psychology research
University of Dhaka, Bangladesh
Hassan El Solh, MD CMO, AUBMC Director July 10, 2017
FP6 Priority 1, Life Sciences Genomics and Biotechnology for Health
Translational Research: Case of Istanbul University
REGULAR EVALUATION OF ESTONIAN RESEARCH AND DEVELOPMENT
Finland, a Global Testbed for Personalized Cancer Research?
The Sahlgrenska Academy
Comparing automated mental health screening to manual processes in a health care system Josh biber.
The Research Landscape: Contextualizing psychology research
NIH at the Crossroads: Myths, Realities and Strategies for the Future
The Sahlgrenska Academy
The Sahlgrenska Academy
FP6 Priority 1, Life Sciences Genomics and Biotechnology for Health
The Nordics – a perfect setting for partnerships and investments
Presentation transcript:

Clinical research in Sweden Current state and prospective Olle Stendahl, MD, PhD Dept. Molecular and Clinical Medicine Faculty of Health Sciences Linköping University

Clinical vs basic medical research ”Nothing is more demanding, more difficult, more frustrating, more time-consuming, and requires more creativity than clinical research” (Vaitukaitis, NIH) ”Basic scientists have to bake bread with clinicians and population biologists”(D. Nathan, Harvard)

Why is translational and clinical research in focus? Quality and development in health care - EBM Global health challanges A new generation of clinical investigators is needed Recruitment is weak MD/PhD students are ”old” New drugs are needed in certain areas A good investment for industry and society The public is interested, informed & demanding

Penicillin (1941) Cortisone (1949) Smoking identified as the cause of lung ca (1950) TB cured with streptomycin and PAS (1950) Polio epidemics and birth of intensive care (1952) Chlorpromazine for treating schizophrenia (1952) Polio vaccination (1955) Open-heart surgery (1955) Charnley’s hip replacement (1961) Kidney transplantation (1963) Cure of childhood cancer (1971) First test-tube baby (1978) Helicobacter as the cause of peptic ulcer (1984)

”He was the first person from the clinical world who’d ever wanted to see my work” ”…suggested he see the crackpot down- stairs who’s trying to prove bacteria cause gastritis” Robin Warren & Barry Marshall Nobel laurates 2005

Characteristics of medical research Genes-function-disease-treatment Multidisciplinary Integration between basic, preclinical and clinical science Large clinical materials and trials Expensive infrastructures Biobanks and records

Exceptional returns One billion SEK in cardiovascular research has lead to reduced mortality worth >100 billion SEK 55 mUS$ in cancer research increased survival from testicular cancer (>90%)

Medical Research is a good investment Losec18,5 billion Nexium24 billion Seloken9 billion Pulmicort7 billion DialysisGambro

Global health challanges Global infections - HIV, malaria, TBC, SARS, Avian Flu… Diabetes Cardiovascul ar disease Cancer Psyciatric diseases

MD&PhD vs PhD % 100%

MD&PhD vs PhD Total PhD exams MD&PhD exams

Academic physicians, MD,PhD MD%Docent% University hopsital5828 Regional hospital164 Private clinics3225 General practise152 (Sjukhusläkaren 4/2004)

What about the new generation? % 2,5% PhD students accepted 2004 Total PhD MD Med. Stud.

Conclusions Fewer postgraduate medical students Fewer clinical investigators and they are too old (>45) 50% of clinical professors (>400) will retire in 5 years

Why do we lack clinical investigators? Clinical work takes too much time No career in sight - no tenure track Clinical science is not in demand Underdeveloped research milieus Weak infrastructure Lack of good projects and leaders Lack of funds for clinical trials

Funding for medical research

Funding for clinical research - 5 billion SEK

Funding of clinical research by industry in Sweden 2.5 billion SEK 5.0 billion SEK Internal costs External costs

Clinical research faces problems in several countries. US, UK and Canada have taken new initiatives Also Sweden must take actions….…

NIH 45% of the budget (26.9 billion) US$ is allocated to clinical and applied medical research

Does Europe have a future in biomedical research? Tom McKillop Pharmaceutical R&D (billion€) Europa USA

Why are we loosing ground? Lack of investment in health care Regulatory barriers Health-care systems and doctors are resistant to innovation Lack of clinical scientists University hospitals are no research hospitals

Clinical trials Clinical trials in Sweden have decreased: 464 (2004) 394 (2005) 4 Billion US$ Clinical contractors Global revenues

The prospects to do clinical research are favourable in Sweden Good medical education Good basic research High quality health care National records and biobanks Strong biomedical industry Trust and support from patients

But Clinical research also requires … Strong research milieus Translational teams Research integrated as part of medical education Regional, national and international collaboration Infrastructure Long-term funding

…and Careers and insentives for clinical investigators

It should be more rewarding for a doctor’s career (and healhcare) to have a PhD in medicine than an MBA

Strategies and possibilities Integrate research in graduate and postgraduate education, and in the clinical work Make both academic and hospital leaders responsible for research Establish research careers and tenure tracks Build translational research teams and clinical research centers Develop national records and biobanks Improve the university hospitals as the most important infrastructure Create a national platform for clinical trials Form a Swedish ”NIH”- ”Research Council for Health”